Sign Up Today and Learn More About Pheon Therapeutics Stock
Invest in or calculate the value of your shares in Pheon Therapeutics or other pre-IPO companies through EquityZen, part of Morgan Stanley.
Pheon Therapeutics Stock (PHET)
Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
About Pheon Therapeutics Stock
Founded
2022
Industries
Natural Resources, Software, Artificial Intelligence
Pheon Therapeutics Press Mentions
Stay in the know about the latest news on Pheon Therapeutics
Pheon Therapeutics discovers new CDCP1-targeting ADCs
bioworld • Jun 10, 2026
Pheon Therapeutics prepares and tests new CDCP1-targeting ADCs
bioworld • May 01, 2026
Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman
pharmiweb • Sep 10, 2025
Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman
prnewswire • Sep 09, 2025
Cytotoxic compounds
patents • Apr 02, 2025
Pheon Therapeutics Management
Leadership team at Pheon Therapeutics
Vice President of R&D and Co-founder
Paul Jackson
Chief Scientific Officer
Leigh Zawel
Join now and verify your accreditation status to gain access to:
- Pheon Therapeutics Current Valuation
- Pheon Therapeutics Stock Price
- Pheon Therapeutics Management
- Available deals in Pheon Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Pheon Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Pheon Therapeutics Revenue and Financials
- Pheon Therapeutics Highlights
- Pheon Therapeutics Business Model
- Pheon Therapeutics Risk Factors
- Pheon Therapeutics Research Report from SACRA Research
Trading Pheon Therapeutics Stock
How to invest in Pheon Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Pheon Therapeutics through EquityZen funds. These investments are made available by existing Pheon Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Pheon Therapeutics stock?
Shareholders can sell their Pheon Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 55K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
